EDGAR Filing Documents for 0001193125-09-255012

Form S-4/A - Registration of securities, business combinations: [Amend]

SEC Accession No. 0001193125-09-255012

Filing Date

2009-12-17

Accepted

2009-12-17 17:27:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PRE-EFFECTIVE AMENDMENT NO.1 TO FORM S-4	ds4a.htm	S-4/A	3172901
2	OPINION OF STRADLING YOCCA CARLSON & RAUTH	dex51.htm	EX-5.1	8977
3	CONSENT OF GRANT THORNTON LLP	dex231.htm	EX-23.1	1664
4	CONSENT OF BDO SEIDMAN, LLP	dex232.htm	EX-23.2	2045
5	CONSENT OF ERNST & YOUNG LLP	dex233.htm	EX-23.3	1542
6	CONSENT OF MERRIMAN CURHAN FORD & CO.	dex992.htm	EX-99.2	2546
7	FORM OF METABASIS PROXY CARD	dex993.htm	EX-99.3	17405
9	GRAPHIC	g24013g24r17.jpg	GRAPHIC	31520
10	GRAPHIC	g24013g94t93.jpg	GRAPHIC	27620
11		filename11.htm	COVER	9061
	Complete submission text file	0001193125-09-255012.txt		3299357

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117

Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500

LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)